SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 230 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $1,695,000 | -26.1% | 58,078 | -22.1% | 0.00% | -70.0% |
Q2 2021 | $2,295,000 | -26.1% | 74,552 | -37.1% | 0.01% | -28.6% |
Q1 2021 | $3,105,000 | +22.1% | 118,609 | +17.3% | 0.01% | 0.0% |
Q4 2020 | $2,543,000 | -27.0% | 101,109 | -39.5% | 0.01% | -36.4% |
Q3 2020 | $3,483,000 | -65.2% | 167,137 | -60.3% | 0.02% | -68.6% |
Q2 2020 | $10,001,000 | +97.7% | 421,100 | +49.8% | 0.07% | +37.3% |
Q1 2020 | $5,058,000 | -33.3% | 281,169 | -12.0% | 0.05% | -1.9% |
Q4 2019 | $7,582,000 | -56.6% | 319,663 | -49.7% | 0.05% | -62.0% |
Q3 2019 | $17,470,000 | -5.5% | 635,748 | +13.8% | 0.14% | -9.9% |
Q2 2019 | $18,488,000 | -58.3% | 558,703 | -55.8% | 0.15% | -27.3% |
Q1 2019 | $44,342,000 | +214.8% | 1,265,460 | +198.5% | 0.21% | +45.1% |
Q4 2018 | $14,085,000 | +2661.8% | 423,964 | +4089.4% | 0.14% | +7100.0% |
Q3 2018 | $510,000 | +5.4% | 10,120 | -68.1% | 0.00% | -60.0% |
Q1 2016 | $484,000 | -79.4% | 31,747 | -81.8% | 0.01% | -77.3% |
Q4 2015 | $2,345,000 | – | 174,513 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |